Oral microbiota imbalance: A predisposing factor for Henoch-Schönlein Purpura in children

Rui Min Li1,2,3, Zhe Long2,3, Xiao Yan Ding2,3

  • 1Department of Operative Dentistry and Endodontics, Stomatology Hospital of General Hospital, Ningxia Medical University, China.

Heliyon
|April 10, 2024
PubMed

Insights

Oral microecological dysregulation is linked to Henoch-Schönlein purpura (HSP) in children. Poor oral health and specific bacterial changes, like reduced Firmicutes, may contribute to HSP development.

Area of Science:

  • Pediatric autoimmune diseases
  • Oral microbiology
  • Immunology

Background:

  • Oral microecological dysregulation is associated with immune disorders.
  • Henoch-Schönlein purpura (HSP) is an autoimmune vasculitis in children with unclear causes.
  • Streptococcal infections are suspected contributors to HSP.

Purpose of the Study:

  • To investigate the oral health status of children with HSP.
  • To analyze oral microbial diversity in children with HSP using 16S rDNA sequencing.
  • To explore the relationship between oral microbiota and HSP development.

Main Methods:

  • Epidemiological survey of oral health in children with HSP.
  • Collection of dental plaque samples from four child groups.
  • 16S rDNA high-throughput sequencing for microbial analysis.

Main Results:

  • Children with HSP exhibited poorer oral health, with higher caries rates and dmfs/DMFS scores in 3-5 year olds compared to national surveys.
  • HSP development is associated with oral microbiota disturbances.
  • A decrease in butyric acid-producing Firmicutes and altered abundance of Streptococcus and Neisseria were observed.

Conclusions:

  • Poor oral health and specific oral microbial changes are linked to Henoch-Schönlein purpura in children.
  • Reduced Firmicutes may play a role in HSP pathogenesis.
  • Alterations in Streptococcus and Neisseria abundance could be risk factors for HSP.

Related Concept Videos

Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
166
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
399
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
412
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.8K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
322
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
578